Literature DB >> 19241371

Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.

Katja Conrath1, Alice S Pereira, Carlos E Martins, Cristina G Timóteo, Pedro Tavares, Silvia Spinelli, Joerg Kinne, Christophe Flaudrops, Christian Cambillau, Serge Muyldermans, Isabel Moura, Jose J G Moura, Mariella Tegoni, Aline Desmyter.   

Abstract

Nitric Oxide Reductase (NOR) is an integral membrane protein performing the reduction of NO to N(2)O. NOR is composed of two subunits: the large one (NorB) is a bundle of 12 transmembrane helices (TMH). It contains a b type heme and a binuclear iron site, which is believed to be the catalytic site, comprising a heme b and a non-hemic iron. The small subunit (NorC) harbors a cytochrome c and is attached to the membrane through a unique TMH. With the aim to perform structural and functional studies of NOR, we have immunized dromedaries with NOR and produced several antibody fragments of the heavy chain (VHHs, also known as nanobodies). These fragments have been used to develop a faster NOR purification procedure, to proceed to crystallization assays and to analyze the electron transfer of electron donors. BIAcore experiments have revealed that up to three VHHs can bind concomitantly to NOR with affinities in the nanomolar range. This is the first example of the use of VHHs with an integral membrane protein. Our results indicate that VHHs are able to recognize with high affinity distinct epitopes on this class of proteins, and can be used as versatile and valuable tool for purification, functional study and crystallization of integral membrane proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241371      PMCID: PMC2760367          DOI: 10.1002/pro.69

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  46 in total

Review 1.  Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains.

Authors:  S Muyldermans; C Cambillau; L Wyns
Journal:  Trends Biochem Sci       Date:  2001-04       Impact factor: 13.807

2.  Degenerate interfaces in antigen-antibody complexes.

Authors:  K Decanniere; T R Transue; A Desmyter; D Maes; S Muyldermans; L Wyns
Journal:  J Mol Biol       Date:  2001-10-26       Impact factor: 5.469

3.  Lateral recognition of a dye hapten by a llama VHH domain.

Authors:  S Spinelli; M Tegoni; L Frenken; C van Vliet; C Cambillau
Journal:  J Mol Biol       Date:  2001-08-03       Impact factor: 5.469

4.  The cytochrome cbb3 from Pseudomonas stutzeri displays nitric oxide reductase activity.

Authors:  E Forte; A Urbani; M Saraste; P Sarti; M Brunori; A Giuffrè
Journal:  Eur J Biochem       Date:  2001-12

5.  Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody.

Authors:  A Desmyter; K Decanniere; S Muyldermans; L Wyns
Journal:  J Biol Chem       Date:  2001-05-07       Impact factor: 5.157

6.  Revisiting the catalytic CuZ cluster of nitrous oxide (N2O) reductase. Evidence of a bridging inorganic sulfur.

Authors:  K Brown; K Djinovic-Carugo; T Haltia; I Cabrito; M Saraste; J J Moura; I Moura; M Tegoni; C Cambillau
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

7.  A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins.

Authors:  Ulrich Rothbauer; Kourosh Zolghadr; Serge Muyldermans; Aloys Schepers; M Cristina Cardoso; Heinrich Leonhardt
Journal:  Mol Cell Proteomics       Date:  2007-10-21       Impact factor: 5.911

8.  Purification, characterization, and preliminary crystallographic study of copper-containing nitrous oxide reductase from Pseudomonas nautica 617.

Authors:  M Prudêncio; A S Pereira; P Tavares; S Besson; I Cabrito; K Brown; B Samyn; B Devreese; J Van Beeumen; F Rusnak; G Fauque; J J Moura; M Tegoni; C Cambillau; I Moura
Journal:  Biochemistry       Date:  2000-04-11       Impact factor: 3.162

9.  Purification and characterization of the single-component nitric oxide reductase from Ralstonia eutropha H16.

Authors:  R Cramm; A Pohlmann; B Friedrich
Journal:  FEBS Lett       Date:  1999-10-22       Impact factor: 4.124

10.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

View more
  14 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  Production, crystallization and X-ray diffraction analysis of a complex between a fragment of the TssM T6SS protein and a camelid nanobody.

Authors:  Van Son Nguyen; Silvia Spinelli; Aline Desmyter; Thi Thu Hang Le; Christine Kellenberger; Eric Cascales; Christian Cambillau; Alain Roussel
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-02-19       Impact factor: 1.056

3.  Camelid nanobodies used as crystallization chaperones for different constructs of PorM, a component of the type IX secretion system from Porphyromonas gingivalis.

Authors:  Yoan Duhoo; Jennifer Roche; Thi Trang Nhung Trinh; Aline Desmyter; Anaïs Gaubert; Christine Kellenberger; Christian Cambillau; Alain Roussel; Philippe Leone
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-04-26       Impact factor: 1.056

4.  Diagnostic evaluation of a nanobody with picomolar affinity toward the protease RgpB from Porphyromonas gingivalis.

Authors:  Peter Durand Skottrup; Paul Leonard; Jakub Zbigniew Kaczmarek; Florian Veillard; Jan Johannes Enghild; Richard O'Kennedy; Aneta Sroka; Rasmus Prætorius Clausen; Jan Potempa; Erik Riise
Journal:  Anal Biochem       Date:  2011-04-20       Impact factor: 3.365

5.  X-ray structure of the mouse serotonin 5-HT3 receptor.

Authors:  Ghérici Hassaine; Cédric Deluz; Luigino Grasso; Romain Wyss; Menno B Tol; Ruud Hovius; Alexandra Graff; Henning Stahlberg; Takashi Tomizaki; Aline Desmyter; Christophe Moreau; Xiao-Dan Li; Frédéric Poitevin; Horst Vogel; Hugues Nury
Journal:  Nature       Date:  2014-08-03       Impact factor: 49.962

6.  Viral infection modulation and neutralization by camelid nanobodies.

Authors:  Aline Desmyter; Carine Farenc; Jennifer Mahony; Silvia Spinelli; Cecilia Bebeacua; Stéphanie Blangy; David Veesler; Douwe van Sinderen; Christian Cambillau
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

Review 7.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

8.  Inhibition of type VI secretion by an anti-TssM llama nanobody.

Authors:  Van Son Nguyen; Laureen Logger; Silvia Spinelli; Aline Desmyter; Thi Thu Hang Le; Christine Kellenberger; Badreddine Douzi; Eric Durand; Alain Roussel; Eric Cascales; Christian Cambillau
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

9.  Nanobody mediated crystallization of an archeal mechanosensitive channel.

Authors:  Christian Löw; Yin Hoe Yau; Els Pardon; Caroline Jegerschöld; Lisa Wåhlin; Esben M Quistgaard; Per Moberg; Susana Geifman-Shochat; Jan Steyaert; Pär Nordlund
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

10.  Crystal structures of two camelid nanobodies raised against GldL, a component of the type IX secretion system from Flavobacterium johnsoniae.

Authors:  Thi Trang Nhung Trinh; Anaïs Gaubert; Pauline Melani; Christian Cambillau; Alain Roussel; Philippe Leone
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2021-05-24       Impact factor: 1.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.